StoxGaudium IVF and Women Health Limited
NSE: GAUDIUMIVF · Unclassified
Ask the data
Instant answers about Gaudium IVF and Women Health Limited — computed from its filings, no language modelPrice & valuation
split & bonus adjusted · pick a metric and rangeAnnual performance
annual · ₹ crore · line = operating margin| FY26 | |
|---|---|
| Revenue | 104.4 |
| EBITDA | 37.7 |
| Operating margin | 36.1% |
| Interest | 3.5 |
| Depreciation | 2.5 |
| Profit before tax | 32.2 |
| Tax | 7.7 |
| Net profit | 24.5 |
| EPS ₹ | 3.92 |
| Operating cash flow | 7.2 |
| Capex | 2.1 |
| Dividend paid | 0.0 |
| Total assets | 193.1 |
| Equity | 152.3 |
Quarterly performance
last 3 quarters · ₹ crore| DEC '25 | MAR '26 | JUN '26 | |
|---|---|---|---|
| Revenue | 24.5 | 30.4 | 19.4 |
| Operating profit | 6.5 | 12.2 | 2.4 |
| Operating margin | 26.7% | 40.1% | 12.5% |
| Other income | 0.1 | 0.2 | 1.1 |
| Interest | 1.2 | 1.3 | 0.4 |
| Depreciation | 0.5 | 0.6 | 0.7 |
| Profit before tax | 5.0 | 10.4 | 2.5 |
| Tax | 1.3 | 2.1 | 0.7 |
| Net profit | 3.6 | 8.4 | 1.8 |
| EPS ₹ | 0.59 | 1.34 | 0.25 |
Returns & margins
trailing-twelve-month, per quarterNot filed yet.
Balance sheet
equity vs borrowings over time · ₹ crore| MAR '26 | |
|---|---|
| Share capital | 36.4 |
| Other equity / reserves | 115.9 |
| Total equity | 152.3 |
| Borrowings | 23.1 |
| Current liabilities | 38.5 |
| Non-current liabilities | 2.3 |
| Total assets | 193.1 |
| Property, plant & equipment | 7.5 |
| Capital work-in-progress | 0.0 |
| Investments | 5.0 |
| Inventories | 3.5 |
| Receivables | 53.4 |
| Cash & equivalents | 8.8 |
Cash flow
annual · ₹ crore · line = free cash flow| FY26 | |
|---|---|
| Cash from operations | 7.2 |
| Cash from investing | -87.7 |
| Cash from financing | 82.0 |
| Capex | 2.1 |
| Free cash flow | 5.1 |
| Dividends paid | 0.0 |
Where the assets sit
Mar '26 · ₹ crorePeer comparison
largest in Unclassified · this company in bold| Company | Market cap ₹cr | Price | P/E | P/B | ROE |
|---|---|---|---|---|---|
| Avantel Limited | 36,86,04,549 | 138.69 | — | 1059360.68 | 0.0% |
| Ducol Organics And Colours Limited | 19,55,275 | 120.00 | — | 20089.13 | 0.0% |
| Jio Platforms Limited | 12,57,181 | 1,406.40 | — | 3.57 | — |
| SBI Funds Management Limited | 1,01,750 | 499.55 | — | — | — |
| Tamilnadu Telecommunication Limited | 91,314 | 9.93 | — | — | — |
| Manipal Health Enterprises Limited | 76,294 | 646.70 | — | — | — |
| INDO-MIM Limited | 59,042 | 1,219.50 | — | — | — |
| AvenuesAI Limited | 45,138 | 129.25 | 153.6 | 9.51 | 6.2% |
| Dhoot Transmission Limited | 32,761 | 1,601.60 | — | 8.11 | — |
| 3M India Limited | 31,071 | 27,570.00 | 53.8 | 17.57 | 32.7% |
| Gaudium IVF and Women Health Limited | 758 | 104.18 | — | 4.98 | — |
StoxGud checklist: Bearish setup · 2/10
- Price above 50-day average
- Price above 200-day average
- 50-day average above 200-day (uptrend)
- RSI in healthy 40–70 zone
- Positive 1-year return
- Return on equity above 15%
- Debt to equity below 1
- Revenue growing year on year
- Net profit margin above 10%
- P/E below industry median
A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.
Returns & technicals
FAQs
What is the share price of Gaudium IVF and Women Health Limited?
Gaudium IVF and Women Health Limited (GAUDIUMIVF) closed at ₹104.18 on NSE on 06 Nov 2026.
What is the market cap of Gaudium IVF and Women Health Limited?
₹758 crore at the latest close.
How fast is Gaudium IVF and Women Health Limited growing?
Not enough filed history yet to measure Gaudium IVF and Women Health Limited's growth.
How profitable is Gaudium IVF and Women Health Limited?
Profitability ratios for Gaudium IVF and Women Health Limited aren't available yet.
How much debt does Gaudium IVF and Women Health Limited have?
Gaudium IVF and Women Health Limited is lightly geared: debt to equity is 0.15 with borrowings of ₹23 cr against cash of ₹9 cr (balance sheet of 2026-03-31).
Financials parsed from Gaudium IVF and Women Health Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from DEC '25, annual from FY26, balance sheet from Mar '26. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.